Skip to content

What can research funding entities do to help progress in MDS with Timothy Graubert, MD
SOHO invests in next generation of hematologic oncologists
Study identifies factors that predict response to imetelstat for MDS treatment
Analysis shows marked difference in treatment patterns, survival between MDS risk groups
Telomere disorders linked to substantial morbidity, clonal hematopoiesis

Insider Reader Survey

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

$Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL$

Cellular Therapy

$Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL$

Leukemia

$Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL$

Lymphoma

$Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL$

Multiple Myeloma

$Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL$

Myelodysplastic Syndromes

$Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL$

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

September 5, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Leukemia Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Cellular Therapy Leukemia Chronic Lymphocytic Leukemia Lymphoma Indolent B-Cell Lymphomas News

Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL

by Kerri Fitzgerald
August 20, 2026
0 Comments

a globe

Leukemia Chronic Lymphocytic Leukemia News

Partnership expands access to CLL treatment in low-, middle-income countries

by SOHO Insider Editors
August 19, 2026
0 Comments

Leukemia Chronic Lymphocytic Leukemia News

Pathways & Perspectives with William Wierda, MD, PhD

by Leah Sherwood
August 5, 2026
0 Comments

FDA laptop

Leukemia Chronic Lymphocytic Leukemia Lymphoma Aggressive B-Cell Lymphomas Myeloproliferative Neoplasms News

FDA approves rituximab biosimilar for B-cell malignancies

by SOHO Insider Editors
August 3, 2026
0 Comments

SOHO 2026 Trending now Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma News Society Updates

Submit an abstract for SOHO 2026 by May 15

by Leah Sherwood
May 9, 2026
0 Comments

CLC_Light_bulbs_icons_300x300_v2

Cellular Therapy Leukemia Chronic Lymphocytic Leukemia News

Sustaining momentum in R/R CLL/SLL care: a five-month follow-up

by sohonews
April 2, 2026
0 Comments

SOHO 2026 Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms Society Updates

Registration now open for SOHO 2026

by SOHO Insider Editors
March 31, 2026
0 Comments

blood smear

Leukemia Chronic Lymphocytic Leukemia Multiple Myeloma

Researchers find concomitant MM and CLL are clonally unrelated

by Leah Sherwood
March 23, 2026
0 Comments

Chinese flag

Leukemia Chronic Lymphocytic Leukemia Lymphoma Indolent B-Cell Lymphomas News

China NMPA approves pirtobrutinib in relapsed/refractory CLL/SLL

by SOHO Insider Editors
March 10, 2026
0 Comments

FDA

Leukemia Chronic Lymphocytic Leukemia Lymphoma Indolent B-Cell Lymphomas News

FDA approves acalabrutinib plus venetoclax for CLL, SLL

by SOHO Insider Editors
February 20, 2026
0 Comments

1
2
3

Top Categories

Cellular Therapy

81

Leukemia

130

Lymphoma

141

Multiple Myeloma

120

Myelodysplastic Syndromes

48

Myeloproliferative Neoplasms

36

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

FDA approves acalabrutinib plus venetoclax for CLL, SLL

Cellular Therapy

FDA approves acalabrutinib plus venetoclax for CLL, SLL

Leukemia

FDA approves acalabrutinib plus venetoclax for CLL, SLL

Lymphoma

FDA approves acalabrutinib plus venetoclax for CLL, SLL

Multiple Myeloma

FDA approves acalabrutinib plus venetoclax for CLL, SLL

Myelodysplastic Syndromes

FDA approves acalabrutinib plus venetoclax for CLL, SLL

Myeloproliferative Neoplasms

Subscribe

Recent Posts

What can research funding entities do to help progress in MDS with Timothy Graubert, MD

SOHO invests in next generation of hematologic oncologists

Study identifies factors that predict response to imetelstat for MDS treatment

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.